Cybin
Latest round
- Seed
Last raised
- Mar 2020
Total raised
- $2.6M
Investors
- 1
About Cybin
, develops psychedelic therapies for mental health disorders. The company was co-founded by Eric So, John Kanakis, and Paul Glavine. The company's platform offers therapeutic development and innovative drug delivery systems. The company uses API Modification, Research and Develop, and Science Meets Technology for its therapeutic development.86 million in its financial year 2020. The acquisition enables Cybin Inc. to scale its intellectual property portfolio in psychedelic drug development.
Who invested in Cybin
1 investor across 1 round
See all investors in Cybin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Mar 1, 2020
Amount
$2.6M
Investors
Questions about Cybin
Who invested in Cybin?
Cybin has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cybin raised?
Cybin has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cybin last raise money?
Cybin's most recent round on record is a Seed, in Mar 2020.
What does Cybin do?
, develops psychedelic therapies for mental health disorders.
Where is Cybin headquartered?
Cybin is headquartered in Toronto, Canada.
Which VCs invest in companies like Cybin?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cybin's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Cybin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.